ESR1 and breast carcinoma: Given that the striking correlation between E2-induced ER binding and H3R26 deimination in MCF-7 cells (a model for ER+ breast cancer), we decided to test whether PAD2 expression and H3R26 deimination may correlate with ER expression in breast tumors.